Palivizumab labels and packages

Revision as of 04:53, 8 January 2014 by ShiSheng (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Palivizumab
SYNAGIS® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels And Packages

[1]

References

  1. ↑ "SYNAGIS (PALIVIZUMAB) INJECTION, SOLUTION [MEDIMMUNE, LLC]". Retrieved 8 January 2014.

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Palivizumab_labels_and_packages&oldid=928048"